Siding With Novo and Lilly, Court Agrees to First Tackle ‘Cross Cutting Issues” in GLP-1 Litigations

In agreeing with Novo Nordisk and Eli Lilly, Pennsylvania judge Karen Spencer Marston said the court should first settle questions of gastroparesis diagnosis and sufficient warnings for side effects.

Scroll to Top